Ep 295 - Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse

In this episode of DeviceTalks Weekly, Host Kayleen Brown talks with Joanna Nathan, CEO and Co-Founder of Prana Surgical, about why catching lung nodules earlier requires a right-sized approach to surgical intervention. Nathan explains Prana’s goal of bringing a lumpectomy approach to lung surgery and how the company is developing its technology to localize and remove nodules while preserving surrounding healthy lung tissue. She distinguishes its initial focus on supporting tissue diagnosis from its longer-term vision of potentially treating lung cancer. Nathan also shares lessons from Prana’s first-in-human experience in Australia, including how observing clinicians using the device helped identify design and workflow improvements. Along the way, she discusses her path from bioengineering to entrepreneurship and how lean medtech teams can use AI while maintaining human oversight. In the FOMO interview, Andy Hansen, Global Director of Engineering at ATL Medical, discusses the future of pulsed field ablation and intravascular lithotripsy. We’ll open the episode with this week’s Newsmakers, covering CMR Surgical’s plans following Stryker’s investment, Intuitive’s U.S. procedure growth and quarterly results, Johnson & Johnson’s timeline for its orthopedics spinoff, Abbott’s planned Nutrition business spinoff, and Medtronic’s appointment of a corporate president. Special thanks to ATL Medical for sponsoring this episode of DeviceTalks Weekly. To learn more about how ATL Medical works with medical device companies, visit: ATLMedical.com. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, Host Kayleen Brown welcomes back Rocco De Bernardis, Global President for Soft Tissue Robotic Surgery at Johnson & Johnson, to discuss the company’s OTTAVA™ Robotic Surgical System. De Bernardis explains why OTTAVA’s four robotic arms are integrated into the operating table and how the system’s smaller footprint could give surgical teams more room to work while helping hospitals bring robotic surgery to additional operating rooms. He also shares what Johnson & Johnson learned from OTTAVA’s clinical trial, including how the system performed in different operating-room environments and what the company’s FDA authorization means as it prepares for a commercial rollout with selected U.S. customers. The conversation also explores the technology behind OTTAVA, including its automated setup and docking, surgical instrumentation, and Polyphonic™, an open digital ecosystem designed to connect data from devices and systems across the operating room. De Bernardis discusses how these technologies could improve workflow, support surgical teams and create a foundation for the future of robotic surgery. Catch the 2023 interview with De Bernardis here: https://www.devicetalks.com/hear-why-j-a-vc-discusses-the-impact-of-glp-1-drugs/ Special thanks to this episode's sponsor, Harmonic Drive. To learn more about how Harmonic Drive works with medical device companies, visit harmonicdrive.net. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Preceptis Medical CEO Dave Carey about his path from MedTech sales to the corner office. Carey shares lessons from launching disruptive technologies at Boston Scientific, Medtronic, Stryker and Pristine Surgical, including what he looks for when hiring salespeople and what it takes to change established clinical workflows. Carey also explains why his new role at Preceptis is personal. After his daughter experienced emergence delirium following anesthesia for an ear tube procedure, Carey was drawn to Hummingbird, Preceptis’ technology for moving ear tube procedures out of the OR and into the physician’s office without general anesthesia. He explains how Preceptis is working with ENTs, pediatricians and parents to drive adoption and why changing even a five-minute procedure requires more than selling a medical device. For more information, visit https://www.hummingbirdeartubes.com. We’ll open the episode with Newmarker’s Newsmakers featuring Mindray, Boston Scientific, Medtronic and Johnson & Johnson MedTech. This episode is sponsored by DeviceTalks Tuesdays Connected Health Series. Register at DeviceTalks.com. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode, MassDevice Editor Chris Newmarker interviews Shan Jegatheeswaran, Global President, Polyphonic, Johnson & Johnson MedTech, about what’s to come after the transformation brought to the operating room by digital surgery and robotics. Jegatheeswaran reports that a new wave of surgical intelligence could take that transformation much further by connecting devices, data, AI and clinicians across the entire perioperative pathway. Jegatheeswaran explains why the biggest challenges may no longer be technological. Interoperability, economic incentives, governance, change management and trust all have to evolve alongside AI and connected medical devices. We’ll open the episode with this week’s Newmarker’s Newsmakers – Petal Surgical, Boston Scientific, Medtronic, Zimmer Biomet and Abbott. This episode is sponsored by DeviceTalks West. Go to west.devicetalks.com. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode, Host Tom Salemi sits down with Eliane Schutte, CEO of Xeltis, to discuss a remarkable biomaterial designed to help the body grow its own living blood vessels. Schutte explains how the technology is being used for dialysis patients today and how it could eventually transform coronary bypass surgery, peripheral vascular care and even heart valve replacement. In the FOMO studio, Tom speaks with Katie Grant, VP of MR at Siemens Healthineers North America, about the global helium supply and why the MRI industry is working to reduce its reliance on the increasingly precious gas. They explore how new magnet designs could make MRI systems lighter, more accessible and easier to install in new locations. As always, we’ll open the podcast with the top stories from MassDevice in Newmarker’s Newsmakers, delivered by MassDevice Editor Chris Newmarker. This week, Chris covers Medtronic’s major investment in surgical robotics, Enovis’ acquisition of eCential Robotics, Stryker’s move to strengthen its shoulder portfolio, the rebranding of Johnson & Johnson MedTech, and job shifts at Zoll Medical. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe